AR118658A2 - COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE - Google Patents

COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE

Info

Publication number
AR118658A2
AR118658A2 ARP200101035A ARP200101035A AR118658A2 AR 118658 A2 AR118658 A2 AR 118658A2 AR P200101035 A ARP200101035 A AR P200101035A AR P200101035 A ARP200101035 A AR P200101035A AR 118658 A2 AR118658 A2 AR 118658A2
Authority
AR
Argentina
Prior art keywords
alas1
dsrna
expression
compositions
seq
Prior art date
Application number
ARP200101035A
Other languages
Spanish (es)
Original Assignee
Icahn School Med Mount Sinai
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icahn School Med Mount Sinai, Alnylam Pharmaceuticals Inc filed Critical Icahn School Med Mount Sinai
Publication of AR118658A2 publication Critical patent/AR118658A2/en

Links

Abstract

Composiciones de ácido ribonucleico bicatenario (dsARN) opcionalmente conjugados a un ligando tal como n-acetilgalactosamina. Los dsARN dirigidas al gen ALAS1. Métodos de uso de tales composiciones de dsARN para alterar (por ejemplo, inhibir) la expresión de ALAS1, tal como tratamientos de sujetos con porfiria. Reivindicación 1: Un ácido ribonucleico bicatenario (dsARN) para inhibir la expresión de ALAS1, en donde dicho dsARN comprende una cadena con sentido y una cadena antisentido, donde la cadena antisentido comprende una región de complementariedad con un transcripto de ARN de ALAS1 (por ejemplo, SEQ ID Nº 1), cuya cadena antisentido comprende al menos 20 nucleótidos contiguos de la secuencia antisentido de UAAGAUGAGACACUCUUUCUGGU (SEQ ID Nº 4153) o UAAGAUGAGACACUCTUUCUGGU (SEQ ID Nº 4154).Double stranded ribonucleic acid (dsRNA) compositions optionally conjugated to a ligand such as n-acetylgalactosamine. The dsRNAs directed to the ALAS1 gene. Methods of using such dsRNA compositions to alter (eg, inhibit) ALAS1 expression, such as treatments of subjects with porphyria. Claim 1: A double stranded ribonucleic acid (dsRNA) for inhibiting the expression of ALAS1, wherein said dsRNA comprises a sense strand and an antisense strand, where the antisense strand comprises a region of complementarity with an ALAS1 RNA transcript (for example , SEQ ID No. 1), whose antisense chain comprises at least 20 contiguous nucleotides of the antisense sequence of UAAGAUGAGACACUCUUUCUGGU (SEQ ID No. 4153) or UAAGAUGAGACACUCTUUCUGGU (SEQ ID No. 4154).

ARP200101035A 2013-10-04 2020-04-13 COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE AR118658A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361887288P 2013-10-04 2013-10-04

Publications (1)

Publication Number Publication Date
AR118658A2 true AR118658A2 (en) 2021-10-20

Family

ID=58698725

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP140103699A AR097920A1 (en) 2013-10-04 2014-10-03 COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GENE SINTASA 1 OF 5-AMINOLEVULIN ACID (ALAS1)
ARP200101035A AR118658A2 (en) 2013-10-04 2020-04-13 COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP140103699A AR097920A1 (en) 2013-10-04 2014-10-03 COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GENE SINTASA 1 OF 5-AMINOLEVULIN ACID (ALAS1)

Country Status (2)

Country Link
AR (2) AR097920A1 (en)
MA (1) MA39000B1 (en)

Also Published As

Publication number Publication date
MA39000B1 (en) 2018-12-31
AR097920A1 (en) 2016-04-20
MA39000A1 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
CO2017007335A2 (en) Suppression of the arni-induced huntingtin gene
AR090869A1 (en) SERPINC1 RNAi COMPOSITIONS AND THEIR METHODS OF USE
PE20171763A1 (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE HAO1 GENE (HYDROXIACIDE-OXIDASE 1 (GLYCOLATE-OXIDASE))
PE20210921A1 (en) ARNI AGENTS AS INHIBITORS OF SERPINE 1 TRANSCRIPTION AND COMPOSITIONS THAT INCLUDE THEM
EA201991369A1 (en) MODIFIED RNA GUIDES
CR20150493A (en) AMRI COMPOSITIONS AGAINST COMPONENT C5 OF THE COMPLEMENT AND METHODS FOR USE
MX2021009118A (en) Compositions and methods for inhibiting expression of the alas1 gene.
AR100946A1 (en) COMPOSITIONS AND METHODS TO REGULATE GENE EXPRESSION THROUGH RNA INTERFERENCE
CO2020015314A2 (en) Arni compositions against angiotensinogen (agt) and methods for their use
CO6690786A2 (en) Polynucleotides and polypeptides encoding abc transporters and modifying their activity in vegetables
CR20160195A (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GEN ALAS 1
WO2015148580A3 (en) Una oligomers having reduced off-target effects in gene silencing
MX2021010716A (en) Compositions and methods for inhibiting expression of the lect2 gene.
BR112016014986A2 (en) mirna type artificial match, composition and method for suppressing expression of a target gene, pharmaceutical composition, method for treating a disease, and single-stranded nucleic acid
ZA202006505B (en) Micro rna expression constructs and uses thereof
CL2021002842A1 (en) Inhibitory double-stranded nucleic acid molecules with shortened sense strands
AR079649A1 (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GENES IL-18
AR118658A2 (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE
CL2013003466A1 (en) Arn construction comprising a sense segment sequence and an antisense of the p0 gene of the genome of the moderate beet yellowing virus (bmyv), a method for inducing tolerance to the bmyv virus.
AR091611A1 (en) OBJECT GENES FOR THE CONTROL OF NUMBER PARASITES OF PLANTS AND THEIR USE
WO2015123561A3 (en) Methods and compositions for inhibiting retinopathy of prematurity
AR090582A1 (en) METHODS AND COMPOSITIONS TO TREAT CANCER USING ARNhc SRC 3 BIFUNCTIONAL
AR121850A2 (en) LPA RNA INTERFERENCE AGENT (RNAi), USE OF SAID AGENT AND METHOD FOR INHIBITING LPA EXPRESSION
AR095559A1 (en) MONOTHERAPY WITH ANTI-CLUSTERINE OLIGONUCLEOTIDES TO TREAT CANCER
AR127137A2 (en) SERPINC1 ARNI COMPOSITIONS AND THEIR METHODS OF USE